Dr. Leon Kircik
Dr. Leon H. Kircik is a board-certified dermatologist who graduated with AOA Honors from The State University of New York at the Health Sciences Center at Brooklyn after completing his undergraduate at New York University. Following completion of his dermatology residency at The State University of New York in Buffalo, he completed a Mohs Micrographic Surgery and Cutaneous Oncology Fellowship under Dr. Frederick Mohs at the University of Wisconsin.
He is an Associate Clinical Professor of Dermatology at Indiana University Medical Center in Indianapolis, and at Icahn School of Medicine at Mount Sinai Medical Center in NYC. Dr. Kircik is also the Medical Director of Derm Research, PLLC and Physicians Skin Care, PLLC in Louisville, Kentucky. He’s been the principal investigator of numerous clinical trials for psoriasis, acne, rosacea, atopic dermatitis, skin cancers, actinic keratosis, and more.
Dr. Kircik’s an author of many articles, abstracts and posters and has lectured extensively nationally and internationally on dermatologic conditions. Additionally, he serves on advisory boards of several pharmaceutical companies. He’s on the editorial board of Journal of Drug in Dermatology, Practical Dermatology, The Journal of Clinical & Aesthetic Dermatology, and Case Report in Clinical Pathology. He volunteers for multiple medical society committees.
SAT Apr 29
Unmasking Acne: A closer look at the unmet needs. A clearer view of the road ahead.
After attending this program, attendees will be able to:
- Recognize current unmet needs in acne management
- Explain the limitations of managing acne with currently available treatment options
- Describe the role of androgens in acne pathophysiology, and select appropriate therapies targeting the androgen pathway
Session description:
Despite the acne treatment landscape continually evolving, there still remain significant unmet needs for patients suffering with moderate-to-severe acne. In this session, Dr. Jaggi Rao will discuss these patient needs, along with gaps and challenges of acne management in Canada, while Dr. Leon Kircik will provide insight into the experience of treating acne in the United States, including the use of the newly available topical agent – clascoterone. The presentations will be tied together through a discussion amongst the panelists led by Dr. Jerry Tan, and the session will conclude with an opportunity for the audience to pose questions to the panel.
